- News & Analysis
Page 828
Betta invests $20m in cancer treatment developer Xcovery
Xcovery has now raised $26m in total, having secured $6m two years ago.
Nov 3, 2014Leeds spin-out regenerates US market
Tissue Regenix has successfully entered the American market.
Nov 3, 2014Alembic takes 49% stake in Adwiya Pharmaceuticals
Alembic Pharmaceuticals has purchased a 49% share of drug manufacturer Adwiya Mami, which will be renamed Alembic Mami.
Oct 31, 2014Quartet counts corporates for $17m series A
Quartet Medicine, a pain and inflammation treatment company, secured the funds from backers including Pfizer, Novartis and Partners Innovation Fund.
Oct 30, 2014Respicardia breathes easier after $20m Sorin investment
Medical device company Sorin invested $20m in the breathing implant developer, and has secured an option to acquire it in future.
Oct 30, 2014Vida takes a lungful of investment
Iowa spin-out Vida secures funding from Next Level Ventures.
Oct 30, 2014Wuxi PharmaTech backs $53m Syros series B
Biotechnology company Syros Pharmaceuticals has raised $53m in a series B round that included Wuxi PharmaTech to develop its gene-control cancer treatment.
Oct 30, 2014Neurostimulation device maker Nevro sets range for IPO
Novo is set to invest up to $16m as the Johnson & Johnson, Covidien and Mayo Clinic-backed company goes public.
Oct 29, 2014About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin